JPMorgan lifts Amorepacific stock rating, raises target to KRW120,000

Published 01/05/2025, 07:36
JPMorgan lifts Amorepacific stock rating, raises target to KRW120,000

On Thursday, JPMorgan analyst Simon Han upgraded Amorepacific Corp (KS:090430:KS) (OTC:AMRPF) stock from Underweight to Neutral and increased the price target to KRW120,000 from KRW99,000. The revision comes after the company reported first-quarter operating profits that exceeded market expectations by 14%. This performance was attributed to several factors, including a return to profitability in China after eight consecutive quarters of losses, strong sales in North America and the EMEA region, and better-than-expected domestic operating profit margins, despite a significant one-time employee incentive provision.

Amorepacific’s success in the western markets was highlighted as particularly encouraging, with the Laneige brand outperforming other K-beauty brands. The company’s diversified product offerings and strong brand equity are expected to drive a 30% year-over-year top-line growth for 2025. Additionally, Amorepacific has developed a solid business model in these regions, leveraging the Sephora channel to ensure growth for its newly launched brands, including Aestura.

The report also noted that the skincare brand COSRX experienced a 35% year-over-year decline in sales, which the analyst believes is now reflected in the current share price, indicating limited downside risk moving forward. Despite the disappointment with COSRX, the overall sentiment for Amorepacific remains positive due to its robust momentum in the western market and the company’s strategic positioning.

The turnaround in China was marked as a positive surprise, but JPMorgan emphasized the need to monitor the sustainability of Amorepacific’s growth and margins in the competitive Chinese market. The company’s ability to maintain profitability in China will be an important factor for future performance assessments.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.